Source: Eur Respir J, 53 (2) 1801895; 10.1183/13993003.01895-2018
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Monique Wapenaar, Jelle R. Miedema, Catharina J. Lammering, Frans W. Mertens, Marlies S. Wijsenbeek. The impact of the new Global Lung Function Initiative T_LCO reference values on trial inclusion for patients with idiopathic pulmonary fibrosis. Eur Respir J, 53 (2) 1801895; 10.1183/13993003.01895-2018

Member's Comments

No comment yet.

Related content which might interest you: Global Lung Function Initiative equations improve interpretation of FEV1 decline among patients with cystic fibrosis Source: Eur Respir J 2015; 46: 262-264 Year: 2015 Evaluation of the Global Lung function Initiative reference values for spirometry and diffusion capacity. Source: Virtual Congress 2021 – Impact of COVID - 19, quality assurance and technology on pulmonary function Year: 2021 Health-related quality of life in idiopathic pulmonary fibrosis (IPF): First results based on the European IPF registry Source: International Congress 2014 – ILDs 1 Year: 2014 Effect of baseline FVC on decline in lung function with nintedanib: Results from the INPULSIS™ trials Source: International Congress 2014 – Clinical trials in IPF Year: 2014 Lung cancer in patients with idiopathic pulmonary fibrosis: Clinical characteristics and impact on survival Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Global Lung Initiative equations for pulmonary hypertension screening in systemic sclerosis Source: Eur Respir J, 52 (3) 1800528; 10.1183/13993003.00528-2018 Year: 2018 Effect of design modifications on trial outcomes in idiopathic pulmonary fibrosis (IPF): Analysis of data from ASCEND and CAPACITY (CAP) Source: International Congress 2014 – IPF and surroundings Year: 2014 Case-finding options for COPD: results from the Burden of Obstructive Lung Disease Study Source: Eur Respir J 2013; 41: 548-555 Year: 2013 Disease progression in IPF assessed using pulmonary function tests and functional respiratory imaging (FRI) – A pilot study Source: International Congress 2014 – COPD and PAH related imaging Year: 2014 Predicting mortality in idiopathic pulmonary fibrosis. Which parameters should be used to determine eligibility for treatment? Analysis of a UK prospective cohort Source: International Congress 2016 – The best is yet to come in terms of lung function Year: 2016 Disease characteristics and outcomes in a Swedish cohort of patients with pulmonary fibrosis (PF) Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Clinical differences between emphysematous and non-emphysematous COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Lung cancer screening in COPD patients: NLST criteria vs a COPD screening score Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Cardiac structure and function at baseline in the DEFLATA study: The impact of lung hyperinflation and its relationship with the GOLD classification Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2014 – ILDs 3 Year: 2014 Correlation of nutritional status using subjective global assessment (SGA) on pulmonary function parameters in patients with COPD at the Philippine Heart Center Source: Annual Congress 2013 –Disease control and quality of life in airway diseases Year: 2013 The European Respiratory Society spirometry tent: a unique form of screening for airway obstruction Source: Eur Respir J 2012; 39: 1458-1467 Year: 2012 The European IPF Registry: Addressing challenges and characteristics of patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014